DRUG

Selinexor

2 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for Selinexor

ALS 1

Mediator Outcome Score Tier Lit. status Trial
XPO1 TDP-43 nuclear export 0.208 Mid novel signal none

Epilepsy 1

Mediator Outcome Score Tier Lit. status Trial
MGMT progression-free survival 0.208 Mid reproduces known none

Clinical trials

199 registered trials for Selinexor

Source: ClinicalTrials.gov